Ascenta Therapeutics
 
Welcome to Ascenta Therapeutics

Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta's current focus is a portfolio of novel, orally-active, small molecule drugs that restore the natural potential for cancer cells to undergo cell death (apoptosis).

Programs and Progress

Multiple Approaches to the Same Goal
Research

Ascenta is developing drugs that target three distinct pathways to cancer cell apoptosis (cell death):